Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure
Digestive and Liver Disease · 2024
DOI: 10.1016/j.dld.2024.04.010 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Digestive and Liver Disease, 2024. Verfasst von A Puente und 24 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Department, Clinical and Traslational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués…. Hauptthemen laut MEDLINE: Oxaliplatin, Colonic Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND AND AIMS: Oxaliplatin (OX) has been described as a potential etiologic agent for porto-sinusoidal vascular disorder (PSVD). Our aim was to describe the natural history of PSVD due to OX in colon cancer (CRC) and identify risk factors for its development. METHODS: We made a multicenter retrospective case-control (ratio 1:3) study with patients diagnosed of PSVD-OX. Baseline data, end of treatment, years of follow-up and diagnosis of PSVD were collected and compared to controls (without PSVD). Besides, 16 different SNPs were selected from bibliography and analyzed by genotyping in the case group to identify potential genetic risk factors. RESULTS: 41 cases were identified, with a median time to PSVD diagnosis after the end of OX of 34 months. Spleen diameter was the strongest predictor of PSVD during treatment (OR 43.94 (14.48-133.336); p < 0.0001). Additionally, thrombocytopenia (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Gastroenterology and Hepatology Department, Clinical and Traslational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital. Santander. Spain. Electronic addre…
- Gastroenterology and Hepatology Department, Clinical and Traslational Research in Digestive Diseases, Valdecilla Research Institute (IDIVAL), Marqués de Valdecilla University Hospital. Santander. Spain.
- Department of Oncology. Marques de Valdecilla University Hospital. IDIVAL. Santander. Spain. Electronic address: marina.serrano92@gmail.com.
- Digestive Diseases Research Unit, Virgen Del Rocío University Hospital.Liver Diseases, Instituto de Biomedicina de Sevilla, IbiS. Cell Biology Department, Faculty of Biology, University of Seville, Seville, Andalusia, S…
- Department of Digestive Diseases. Hospital Ramón y Cajal. CIBEREHD. Madrid. Spain.
- Barcelona Hepatic Hemodynamic Lab. Liver Unit. Hospital Clinic. IDIBAPS. University of Barcelona. Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN-Liver). CIBEREHD. Barcelona. Spain.
Zitieren
APA
Puente, A., Fortea, J. I., Del Pozo, C., Serrano, M., Alonso-Peña, M., Giráldez, A., Tellez, L., Martinez, J., Magaz, M., Ibañez, L., Garcia, J., Llop, E., Alvarez-Navascues, C., Romero, M., Rodriguez, E., Arias Loste, M. T., Antón, A., Echavarria, V., López, C., …, & by REHEVASC group (2024). Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure. Digestive and Liver Disease. https://doi.org/10.1016/j.dld.2024.04.010
Vancouver
Puente A, Fortea JI, Del Pozo C, Serrano M, Alonso-Peña M, Giráldez A, et al. Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure. Digestive and Liver Disease. 2024. doi:10.1016/j.dld.2024.04.010
BibTeX
@article{Puente2024,
author = {Puente, A and Fortea, J I and Del Pozo, C and Serrano, M and Alonso-Peña, M and Giráldez, A and Tellez, L and Martinez, J and Magaz, M and Ibañez, L and Garcia, J and Llop, E and Alvarez-Navascues, C and Romero, M and Rodriguez, E and Arias Loste, M T and Antón, A and Echavarria, V and López, C and Albillos, A and Hernández-Gea, V and Garcia-Pagán, J C and Bañares, R and Crespo, J and by REHEVASC group, by REHEVASC group},
title = {Clinical and genetic factors involved in Porto-sinusoidal vascular disorder after oxaliplatin exposure},
journal = {Digestive and Liver Disease},
year = {2024},
doi = {10.1016/j.dld.2024.04.010}
}
EUVIMED